Cimzia 2X200 MG/ML syringe kits
Ended Awarded
- Contract number
- SPE2DB25FU9VS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,395
Award facts
- Contract value 100% obligated
- $13,394.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,394.81 to AmerisourceBergen Drug Corp for the supply of Cimzia 2x200 mg/ml syringe kits, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, non-set-aside contract utilizing a competitive award process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in Conshohocken, PA 19428. The delivery order is issued under the company's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026.
This delivery order represents a routine pharmaceutical procurement supporting federal military and veteran healthcare systems. Cimzia is a TNF inhibitor used to treat inflammatory conditions and is part of the comprehensive pharmaceutical portfolio that AmerisourceBergen Drug Corp supplies to federal customers through the SPE2DX vehicle. The firm fixed-price structure ensures cost predictability for the government, while the non-set-aside designation reflects the company's demonstrated capability to compete successfully for federal pharmaceutical procurement requirements. As the prime contractor under this delivery order, AmerisourceBergen Drug Corp has established itself as a critical vendor within the federal medical supply chain, serving multiple federal agencies including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FU9VS?
SPE2DB25FU9VS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FU9VS worth?
The government has obligated $13,395 on SPE2DB25FU9VS.
Is contract SPE2DB25FU9VS an order under another contract?
Yes. SPE2DB25FU9VS is a delivery order under SPE2DB22D1052, an indefinite delivery contract.
Was contract SPE2DB25FU9VS competed?
The extent of competition for SPE2DB25FU9VS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award